A decade in drug discovery.
- Published in:
- 2012
- Publication type:
- Editorial
Works matching IS 14741776 AND DT 2012 AND VI 11 AND IP 1
Results: 27
1
2
Mark Fishman. Interview by Asher Mullard.
- Published in:
- 2012
- By:
- Publication type:
- Interview
3
Interfacial inhibitors: targeting macromolecular complexes.
- Published in:
- 2012
- By:
- Publication type:
- journal article
4
Market watch: Upcoming market catalysts in Q1 2012.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 1, p. 10, doi. 10.1038/nrd3632
- By:
- Publication type:
- Article
5
Interfacial inhibitors: targeting macromolecular complexes.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 1, p. 25, doi. 10.1038/nrd3404
- By:
- Publication type:
- Article
6
Vaccines: Enhancing glycan presentation increases vaccine efficacy.
- Published in:
- 2012
- By:
- Publication type:
- journal article
7
New neglected disease research scheme pools IP and expertise.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 1, p. 5, doi. 10.1038/nrd3642
- By:
- Publication type:
- Article
8
Computational chemistry: Crowd-based enhancement of chemical diversity.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 1, p. 21, doi. 10.1038/nrd3646
- By:
- Publication type:
- Article
9
Designing antimicrobial peptides: form follows function.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 1, p. 37, doi. 10.1038/nrd3591
- By:
- Publication type:
- Article
10
G protein-coupled receptors: Case builds for TGR5 as metabolic syndrome target.
- Published in:
- 2012
- By:
- Publication type:
- journal article
11
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 1, p. 1, doi. 10.1038/nrd3639
- Publication type:
- Article
12
Antiparasitic drugs: Two-pronged tactics for malaria control.
- Published in:
- 2012
- By:
- Publication type:
- journal article
13
2011 in reflection.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 1, p. 6, doi. 10.1038/nrd3643
- By:
- Publication type:
- Article
14
Kinase inhibitors: Analysing kinase inhibitor selectivity.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 1, p. 21, doi. 10.1038/nrd3647
- By:
- Publication type:
- Article
15
A decade in drug discovery.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 1, p. 3, doi. 10.1038/nrd3648
- Publication type:
- Article
16
A decade of change.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 1, p. 17, doi. 10.1038/nrd3630
- By:
- Publication type:
- Article
17
Deal watch: High hopes for oral SYK inhibitor in rheumatoid arthritis.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 1, p. 10, doi. 10.1038/nrd3631
- By:
- Publication type:
- Article
18
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 1, p. 9, doi. 10.1038/nrd3644
- Publication type:
- Article
19
Brentuximab vedotin.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 1, p. 19, doi. 10.1038/nrd3629
- By:
- Publication type:
- Article
20
Targeting proteinase-activated receptors: therapeutic potential and challenges.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 1, p. 69, doi. 10.1038/nrd3615
- By:
- Publication type:
- Article
21
Cancer: Opening the door to a new class of proteasome inhibitors.
- Published in:
- 2012
- By:
- Publication type:
- journal article
22
Neurodegenerative disease: Inhibiting ?-secretase in humans.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 1, p. 21, doi. 10.1038/nrd3645
- By:
- Publication type:
- Article
23
Patent watch.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 1, p. 12, doi. 10.1038/nrd3641
- By:
- Publication type:
- Article
24
The pharmacological landscape and therapeutic potential of serine hydrolases.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 1, p. 52, doi. 10.1038/nrd3620
- By:
- Publication type:
- Article
25
Trial watch: PCSK9 antibody reduces LDL cholesterol.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 1, p. 11, doi. 10.1038/nrd3633
- By:
- Publication type:
- Article
26
Neurodegenerative disease: Novel ALS therapy shows promise in Phase II.
- Published in:
- 2012
- By:
- Publication type:
- journal article
27
Mark Fishman.
- Published in:
- 2012
- Publication type:
- Interview